Tue, March 6, 2018
Mon, March 5, 2018
Fri, March 2, 2018
Thu, March 1, 2018
Wed, February 28, 2018
Tue, February 27, 2018
Mon, February 26, 2018
Fri, February 23, 2018
Thu, February 22, 2018
Wed, February 21, 2018
Tue, February 20, 2018
Fri, February 16, 2018
Thu, February 15, 2018

David Lewis Maintained (ZBH) at Buy with Decreased Target to $148 on, Feb 26th, 2018


//stocks-investing.news-articles.net/content/201 .. th-decreased-target-to-148-on-feb-26th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Buy with Decreased Target from $150 to $148 on, Feb 26th, 2018.

David has made no other calls on ZBH in the last 4 months.



There are 6 other peers that have a rating on ZBH. Out of the 6 peers that are also analyzing ZBH, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Isaac Ro of "Goldman Sachs" Upgraded from Strong Sell to Hold on, Wednesday, December 20th, 2017
  • Matthew O'Brien of "Piper Sandler" Downgraded from Buy to Hold on, Thursday, November 2nd, 2017


These are the ratings of the 4 analyists that currently disagree with David


  • Richard Newitter of "Leerink Swann" Maintained at Buy with Increased Target to $146 on, Wednesday, January 31st, 2018
  • Rick Wise of "Stifel" Upgraded from Hold to Strong Buy on, Wednesday, January 31st, 2018
  • Kristen Stewart of "Deutsche Bank" Upgraded from Hold to Strong Buy on, Tuesday, November 14th, 2017
  • Joanne Wuensch of "BMO Capital" Maintained at Buy with Decreased Target to $135 on, Thursday, November 2nd, 2017

Publication Contributing Sources